FDA Approves Cholesterol-Lowering siRNA Therapy
MedPage Today) — FDA finally approved inclisiran (Leqvio), making it the first small interfering RNA (siRNA) therapy to hit the market for reducing LDL cholesterol, Novartis announced on Wednesday. The PCSK9 inhibitor was handed an indication…
Read more